Private equity (PE) firms have increased their ownership stake across health care sectors in the US. PE’s focus on short-term profitability may decrease the provision of unprofitable services, ...

In a now-deleted TikTok that raked in millions of views, Esther Jeong, from California, explained that she was recently ...

Botox, fillers, and other injectable procedures always carry a risk, but for Esther Jeong, the consequences were catastrophic ...

Retinal pigment epithelial detachment is associated with neovascular age-related macular degeneration in 30% to 80% of cases, according to the literature.It is often difficult to treat, requires a ...

to achieve therapeutic levels of gene expression in photoreceptors of the central retina while avoiding the surgical risks of foveal detachment. “We’re honored that the FDA has granted Regenerative ...

Pars plana vitrectomy is a safe and effective surgery that is essential in the treatment of a variety of posterior segment ...

Dr. Michael Kapusta, MD, FRSCS, Ophthalmologist, talks about Retinal Detachment Treatment - Pneumatic Retinoplexy ...

Pykus Therapeutics announced it has completed enrollment in its pilot study, PYK-2101-RD00, evaluating PYK-2101, a focal ...

CAMBRIDGE, Mass., April 10, 2025 /PRNewswire/ -- Pykus Therapeutics, Inc. ("Pykus" or the "Company") announced today that it has completed enrollment of its pilot study (PYK-2101-RD001) in Australia.

The Company is pursuing an initial indication for the treatment of retinal detachment. PYK-2101 offers the opportunity to dramatically improve and accelerate visual recovery following retinal ...

with an initial prospective indication for the treatment of retinal detachment. The company states that “PYK-2101 offers the opportunity to dramatically improve and accelerate visual recovery ...

Berlin: Bayer has submitted an application to the European Medicines Agency (EMA) seeking approval of aflibercept 8 mg (114.3 mg/ml solution for injection) for the treatment of patients with macular ...